EDAP TMS SA announced the successful treatment of the first patient in its phase I/II PULS Trial, which is investigating the use of High Intensity Focused Ultrasound (HIFU) technology for pancreatic ...
AUSTIN, Texas, January 8, 2025 - EDAP TMS SA (EDAP), the global leader in robotic energy-based therapies, today announced that the first patient has been treated in a phase I/II PULS Trial sponsored ...
LYON, France, October 1, 2024 - EDAP TMS SA (EDAP), the global leader in robotic energy-based therapies, today announced that the first patients have been treated in a Phase I/II study evaluating the ...
The Punch on MSN
Emergence of HIFU treatment for prostate cancer, tumours, a game-changer – Specialists
Discover how High-Intensity Focused Ultrasound (HIFU) treatment is revolutionizing care for prostate cancer and tumours with ...
John Wayne Cancer Institute (JWCI) at Providence Saint John’s Health Center is once again breaking new ground to benefit cancer patients. It has become the first medical center in the country to ...
Medical professionals have described the introduction of High-Intensity Focused Ultrasound (HIFU) technology for treating fibroids in Nigeria as a significant feat. The deployment of the technology by ...
CHARLOTTE, NC / ACCESSWIRE / April 16, 2024 / HIFU Prostate Services, LLC (HPS), the leading provider of non-invasive prostate cancer treatments, using High Intensity Focused Ultrasound (HIFU), is ...
(MENAFN- EIN Presswire) EINPresswire/ -- I. Company Overview: Huamei's Leadership in Advanced Aesthetic Technology Located in Shandong, China, Shandong Huamei Technology Co., Ltd. has established ...
Hosted on MSN
VCU Massey Comprehensive Cancer Center in Richmond offers new non-surgical robotic for prostate cancer
RICHMOND, Va. (WRIC) — Virginia Commonwealth University’s (VCU) Massey Comprehensive Cancer Center in Richmond is the first site in Virginia to offer a new non-surgical robotic ultrasound procedure ...
AUSTIN, Texas, January 8, 2025 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that the first patient has been treated in a phase I/II PULS Trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results